Nls Pharma

Developer of small molecule therapeutics for CNS, mental and behavioral disorders

placeStansstad, Nidwalden, Switzerland calendar_todayFounded 2015 groups250 employees language nlspharma.com

Innovation

3 patent families (3 granted) — focus: Human necessities; filing pace dormant. Cited 71 times.

YearFilings
20161
20172
20182
20191
20202

Investor mix

1 investor on record.

Investor typeCountShare
Private equity1100%
Coming soon